Back to Search
JOSEPH PRESTI, MD
MD
Urology Physician
NPI: 1265588933IndividualAccepts Medicare
Specialties, Licenses & Credentials
Urology PhysicianPrimary
Urology
Code: 208800000X
G056934(CA)
CMS Specialties
PrimaryUROLOGY
Education
UNIVERSITY OF CALIFORNIA, IRVINE, CALIFORNIA COLLEGE OF MEDICINE
Class of 1984
Research & Publications (20)
The use of prostate-specific antigen kinetics to stratify risk in prostate cancer.
PMID 18765117·Curr Urol Rep·2008
6-review
Does the yield of prostate cancer biopsy and repeat biopsy justify the frequency of their use?
PMID 18364716·Nat Clin Pract Urol·2008
8-other
Lower body mass index is associated with a higher prostate cancer detection rate and less favorable pathological features in a biopsy population.
PMID 15126785·J Urol·2004
8-other
Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study.
PMID 12478119·J Urol·2003
8-other
Allelic loss on chromosomes 8 and 9 correlates with clinical outcome in locally advanced clear cell carcinoma of the kidney.
PMID 11832771·J Urol·2002
8-other
The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial.
PMID 10604337·J Urol·2000
3-trial
Prostate cancer: assessment of risk using digital rectal examination, tumor grade, prostate-specific antigen, and systematic biopsy.
PMID 10664666·Radiol Clin North Am·2000
6-review
Predictors of secondary treatment following biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital database.
PMID 19522861·BJU Int·2010
4-observational
The influence of prostate volume on prostate-specific antigen performance: implications for the prostate cancer prevention trial outcomes.
PMID 19584168·Clin Cancer Res·2009
8-other
Race and time from diagnosis to radical prostatectomy: does equal access mean equal timely access to the operating room?--Results from the SEARCH database.
PMID 19336564·Cancer Epidemiol Biomarkers Prev·2009
8-other
Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells.
PMID 19666525·Proc Natl Acad Sci U S A·2009
7-preclinical
Exposure to Agent Orange is a significant predictor of prostate-specific antigen (PSA)-based recurrence and a rapid PSA doubling time after radical prostatectomy.
PMID 19298411·BJU Int·2009
4-observational
Preoperative predictors of blood loss at the time of radical prostatectomy: results from the SEARCH database.
PMID 19322137·Prostate Cancer Prostatic Dis·2009
8-other
Body mass index and prostate specific antigen as predictors of adverse pathology and biochemical recurrence after prostatectomy.
PMID 19524974·J Urol·2009
4-observational
Validation of a nomogram to predict disease progression following salvage radiotherapy after radical prostatectomy: results from the SEARCH database.
PMID 19466946·BJU Int·2009
4-observational
Obesity as a predictor of adverse outcome across black and white race: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database.
PMID 19670453·Cancer·2009
8-other
Does early prostate-specific antigen doubling time (ePSADT) after radical prostatectomy, calculated using PSA values from the first detectable until the first recurrence value, correlate with standard PSADT? A report from the Shared Equal Access Regional Cancer Hospital Database Group.
PMID 19549124·BJU Int·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 275 W MACARTHUR BLVD
OAKLAND, CA 94611 - Phone
- (510) 752-1000
Quick Facts
- NPI
- 1265588933
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 42
- Publications
- 20
Are you this provider?
Claim Your Profile